Resveratrol mitigated myocardial damage by suppressing ferroptosis via the activation of KAT5/GPX4 in MI, offering additional evidence for its potential therapeutic efficacy (Liu J. et al., 2022). The gene discussed is GPX4; the disease is myocardial infarction.